12:00 AM
Nov 19, 2012
 |  BC Week In Review  |  Company News  |  Deals

Bellus Health, Asclepios Bioresearch Ltd. deal

In its 3Q12 earnings, Bellus said that it and venture capital firm Asclepios partnered during the quarter to develop Bellus' BLU8499 (formerly NRM8499) to treat Alzheimer's...

Read the full 126 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >